Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

SpectRx Inc.

BioPhotonics
Nov 2006
SpectRx Inc. of Norcross, Ga., has received a fifth grant worth $690,000 from the National Cancer Institute (NCI) in Bethesda, Md. The company has been awarded a total of $3.2 million in NCI funding to finance an ongoing FDA trial of its noninvasive cervical cancer detection device, which measures light reflected from the cervix and which produces a diagnostic image. The trial is expected to be finished in 2007.

BiophotonicsBusinessRapidScan

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.